Skip to main content
Neurotherapeutics logoLink to Neurotherapeutics
. 2023 May 3;20(3):909. doi: 10.1007/s13311-023-01381-5

Correction to: BDNF Augmentation Using Riluzole Reverses Doxorubicin-Induced Decline in Cognitive Function and Neurogenesis

Manal T Usmani 1, Robert P Krattli Jr 1, Sanad M El-Khatib 1, Anh C D Le 1, Sarah M Smith 2, Janet E Baulch 2, Ding Quan Ng 3,4, Munjal M Acharya 1,2,, Alexandre Chan 3,4,
PMCID: PMC10275834  PMID: 37138161

Correction to: Neurotherapeutics https://doi.org/10.1007/s13311-022-01339-z

The following correction should be noted to the caption for Fig. 5 in the article as original published:

"...the percentage of BrdU+ cells (red) differentiating into the mature neurons (green, NeuN; C, c1, E)."

should have read

"...the percentage of BrdU+ cells (green) differentiating into the mature neurons (red, NeuN; C, c1, E)."

The original article has been corrected.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Contributor Information

Munjal M. Acharya, Email: macharya@uci.edu

Alexandre Chan, Email: a.chan@uci.edu.


Articles from Neurotherapeutics are provided here courtesy of Elsevier

RESOURCES